Bank Of America Corp Omega Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 16,597 shares of OMGA stock, worth $13,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,597

Previous 10,460 58.67%

Holding current value

$13,775

Previous $21,000 4.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.22 - $2.25 $7,487 - $13,808	6,137 Added 58.67%	16,597 $20,000
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.2 $20,824 - $35,827	-11,196 Reduced 51.7%	10,460 $21,000
Q1 2024 May 15, 2024	SELL	$2.73 - $5.32 $101,820 - $198,420	-37,297 Reduced 63.27%	21,656 $79,000
Q4 2023 Feb 14, 2024	BUY	$1.35 - $3.21 $61,676 - $146,652	45,686 Added 344.36%	58,953 $177,000
Q2 2023 Aug 14, 2023	SELL	$5.6 - $9.66 $100,212 - $172,865	-17,895 Reduced 57.43%	13,267 $74,000
Q1 2023 May 12, 2023	BUY	$4.81 - $10.95 $104,925 - $238,863	21,814 Added 233.35%	31,162 $187,000
Q4 2022 Feb 10, 2023	BUY	$4.22 - $7.05 $3,835 - $6,408	909 Added 10.77%	9,348 $53,000
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $16,999 - $31,141	4,683 Added 124.68%	8,439 $46,000
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $25,028 - $89,529	-12,452 Reduced 76.83%	3,756 $14,000
Q1 2022 May 16, 2022	BUY	$6.24 - $14.04 $42,350 - $95,289	6,787 Added 72.04%	16,208 $101,000
Q4 2021 Feb 08, 2022	BUY	$11.33 - $29.38 $103,080 - $267,299	9,098 Added 2816.72%	9,421 $107,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $5,168 - $7,270	323 New	323 $6,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $39.7M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Omega Therapeutics, Inc. Transaction History